Bio Green Papers reports consolidated net profit of Rs 5.38 crore in the June 2024 quarter

Bio Green Papers reports consolidated net profit of Rs 5.38 crore in the June 2024 quarter


Sales reported at Rs 50.02 crore

Net profit of Bio Green Papers reported to Rs 5.38 crore in the quarter ended June 2024 as against net loss of Rs 0.75 crore during the previous quarter ended June 2023. Sales reported to Rs 50.02 crore in the quarter ended June 2024. There were no Sales reported during the previous quarter ended June 2023.

ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales50.020 0 OPM %13.210 PBDT6.62-0.67 LP PBT5.38-0.75 LP NP5.38-0.75 LP

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 24 2024 | 5:35 PM IST



Source link

Bio Green Papers reports consolidated net profit of Rs 5.38 crore in the June 2024 quarter

CRISIL reaffirms ratings of DCM Shriram at 'A1+'


DCM Shriram said that CRISIL Ratings has reaffirmed its ‘CRISIL A1+’ rating on the commercial paper of the company.

CRISIL Ratings stated that the companys operating income declined by 5% to Rs.10,922 crores in FY24 from Rs.11,547 crores in FY23 mainly due to weak performance of Chloro Vinyl segment which was partly offset by healthy performance across sugar and other segments. Chloro vinyl segment reported 31% decline in its revenue due to fall in realisations for caustic soda and PVC resins.

This has impacted the segment profitability as well leading to decline in overall EBIDTA margins to 9.1% in FY24 compared to 13.9% in FY23. In Q1-fiscal 2025, company reported revenue of Rs.2,876 crores with EBIDTA margins at 8.6%.

With commissioning of 850 TPD caustic soda plant, CRISIL Ratings expects revenue growth to remain healthy at 8-10% mainly driven by incremental volumes from the newly commissioned capacity. Operating profitability is expected to improve to 10-12% in medium term supported by improved cost efficiency with commissioning of captive power plants. The revenue and profitability of DCM will continue to be supported by the diversity in the business profile.

The company has completed its major capex plans which includes 850 TPD expansion in caustic soda and 120 MW power plant in Q1 fiscal 2025 while Hydrogen peroxide and Epichlorohydrin plant are under final stages of completion. The expansion project under sugar segment is expected to be completed this fiscal with studies underway for proposed Epoxy plant project.

Gross debt is expected to increase towards the capex this fiscal. The financial risk profile should remain strong, despite the debt-funded capex, supported by expected steady cash accrual and healthy liquidity.

The rating continues to reflect a healthy and diversified business risk profile and strong financial risk profile of DCM, indicated by comfortable debt protection metrics, healthy capital structure and ample liquidity. These strengths are partially offset by risks related to volatility in the sugar, chlor-alkali and plastics segments and exposure to risks related to regulatory changes in the sugar and fertilizer industries.

DCM is a diversified business group, with presence across the chloro-vinyl (chlor-alkali and plastics), sugar and agricultural inputs (farm solutions; urea and bioseed) businesses. The company is also engaged in Fenesta building system and cement. It operates its chlor-alkali, plastics, urea, and cement businesses from Kota and chlor-alkali operations from Bharuch, where it has captive power plants. The company has four sugar mills in central Uttar Pradesh, with a bioseed division in Hyderabad.

The scrip had advanced 1.34% to end at Rs 1177.60 on the BSE on Friday.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 24 2024 | 5:06 PM IST



Source link

Bio Green Papers reports consolidated net profit of Rs 5.38 crore in the June 2024 quarter

Alembic Pharma gets USFDA nod for Betamethasone Valerate Foam


Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Betamethasone Valerate Foam.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Luxiq Foam of Norvium Bioscience, LLC (Norvium).

Betamethasone valerate foam is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.

The company has a cumulative total of 213 ANDA approvals (185 final approvals and 28 tentative approvals) from USFDA.

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.

The pharmaceutical companys consolidated net profit increased 11.69% to Rs 134.71 crore in Q1 FY25 as compared to Rs 120.60 crore posted in Q1 FY24. Revenue from operations grew 5.09% year on year (YoY) to Rs 1,561.73 crore in the quarter ended 30 June 2024.

The scrip slipped 1.50% to settle at Rs 1,100.55 on Friday, 23 August 2024.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 24 2024 | 4:59 PM IST



Source link

Auto parts maker Carraro India files papers with Sebi for Rs 1812 crore IPO

Auto parts maker Carraro India files papers with Sebi for Rs 1812 crore IPO



Auto parts maker Carraro India, a manufacturer of axles and transmission systems for agricultural tractors and construction vehicles, is planning to raise nearly Rs 1,812 crore through an initial public offering (IPO), reported Moneycontrol. The company submitted its draft papers to the capital markets regulator SEBI on August 23.


The parent company of Carraro International SE, Italy-based Carraro SpA, is the head of the Carraro Group. The group specialises in manufacturing transmission systems—including axles, transmissions, and drives—for off-highway agricultural and construction equipment.


The IPO consists entirely of an offer-for-sale worth Rs 1,811.65 crore by its promoter Carraro International SE, which functions as a holding company for investments, the report said. Consequently, all proceeds from the IPO will go directly to the selling shareholder, leaving Carraro India without any financial benefit from the public offering.


Carraro India financials 


Despite modest growth in revenue, Carraro India saw its profit rise by 29.4 per cent to Rs 60.6 crore in FY24, compared to Rs 47 crore in the previous year, driven by robust operational performance.


The company’s revenue for the fiscal year ending in March 2024 stood at Rs 1,770.5 crore, reflecting a 4.4 per cent rise compared to the prior year. EBITDA (earnings before interest, tax, depreciation, and amortisation) grew by 27.2 per cent year-on-year to Rs 128.2 crore, with the EBITDA margin improving by 130 basis points to 7.2 percent in FY24, Moneycontrol added.


Founded in 1997, Carraro India competes with publicly listed companies such as Escorts Kubota, Schaeffler India, Sona BLW Precision Forgings, Ramakrishna Forgings, Happy Forgings, and Action Construction Equipment. The company produces backhoe loaders, soil compactors, cranes, self-loading concrete mixers, and small motor graders for the agricultural and construction sectors. It also supplies gears, shafts, and ring gears for industrial and automotive applications.


Operating from two manufacturing facilities in Pune, the company supplied products to 38 manufacturers across India in FY24, with domestic sales accounting for 64.82 percent of its revenue in the last fiscal year, the report said.

First Published: Aug 24 2024 | 12:30 PM IST



Source link

Aeron Composite fixes price band at Rs 121-125 a share for Rs 56 cr IPO

Aeron Composite fixes price band at Rs 121-125 a share for Rs 56 cr IPO


The IPO is entirely a fresh issue of 44.88 lakh equity shares of face value Rs 10 each.


Aeron Composite Ltd on Saturday said it has fixed the price band at Rs 121-125 per share for its SME initial public offering which will open for subscription on August 28.


The company plans to raise up to Rs 56.10 crore from its SME public issue, Aeron Composite said in a statement.


The company has received approval to launch its public issue on NSE Emerge Platform of the National Stock Exchange, it added.


The public issue will conclude on August 30. Investors can bid for a minimum of 1,000 shares and in multiples thereof.


The IPO is entirely a fresh issue of 44.88 lakh equity shares of face value Rs 10 each.


Retail investor quota for the initial public offering (IPO) is kept at not less than 35 per cent of the net offer, Non institutional investor quota is kept at not less than 15 per cent of the offer and QIB portion is kept at not more than 50 per cent of the offer.


The company has proposed to utilise IPO proceeds for funding the capital expenditure requirements towards setting up of an additional manufacturing unit at Mehsana, Gujarat and general corporate purposes.


The company reported revenue of Rs 179.1 crore for FY 2023-24 (till February 2024) and net profit stood at Rs 9.42 crore during the period.


Aeron Composite Ltd is engaged in the business of manufacturing and supplying of Fiberglass Reinforced Polymer Products i.e. FRP products including, FRP Pultruded Products, FRP Moulded Gratings & FRP Rods tailored for various industrial applications.


It exports products to more than 30 countries.


Hem Securities Ltd is the sole book running lead manager, while Maashitla Securities Pvt Ltd is the registrar for the issue.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Aug 24 2024 | 4:10 PM IST



Source link

Bio Green Papers reports consolidated net profit of Rs 5.38 crore in the June 2024 quarter

Ashoka Buildcon emerges as L-1 bidder for MMRDA project


Ashoka Buildcon informed that it has emerged as the lowest bidder (L-1) for a project worth Rs 478 crore awarded by Mumbai Metropolitan Region Development Authority (MMRDA).

The said project includes design and construction of elevated road from Kalyanmurbad Road (Palms Water Resort) to Badlapur Road (Jagdish Dughdhalaya) to Pune Link Road parallel to Waldhuni River crossing over Karjat- Kasara Railway line including slip road.

The company has quoted bid price of Rs 478 crore and it will be executed within 36 months including monsoon period.

Ashoka Buildcon is engaged in construction & maintenance of roads and supporting services to land support-operation of toll roads.

The company has reported a standalone net profit of Rs 40.8 crore in Q1 FY25, which is significantly higher as compared with the PAT of Rs 16.4 crore in Q1 FY24. Total income rose by 22% year-over-year (YoY) to Rs 1,900.8 crore during the period under review.

The scrip declined 1.13% to settle at Rs 232.40 on Friday, 23 August 2024.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 24 2024 | 4:03 PM IST



Source link

YouTube
Instagram
WhatsApp